ERBB2 and breast carcinoma: Researchers have demonstrated the effectiveness of treatments that target metabolism in improving anticancer therapies or reversing drug resistance in breast cancer cells, such as resistance to chemotherapy, endocrine therapy, and HER-2 targeted treatment.